AAAAAA
Results:
1-24
|
Results: 24
Authors:
KLINE MW
FLETCHER CV
HARRIS AT
EVANS KD
BRUNDAGE RC
REMMEL RP
CALLES NR
KIRKPATRICK SB
SIMON C
Citation: Mw. Kline et al., A PILOT-STUDY OF COMBINATION THERAPY WITH INDINAVIR, STAUVIDINE (D4T), AND DIDANOSINE (DDI) IN CHILDREN INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of pediatrics, 132(3), 1998, pp. 543-546
Authors:
FLETCHER CV
ACOSTA EP
HENRY K
PAGE LM
GROSS CR
KAWLE SP
REMMEL RP
ERICE A
BALFOUR HH
Citation: Cv. Fletcher et al., CONCENTRATION-CONTROLLED ZIDOVUDINE THERAPY, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 331-338
Authors:
ACOSTA EP
FLETCHER CV
Citation: Ep. Acosta et Cv. Fletcher, VALACYCLOVIR, The Annals of pharmacotherapy, 31(2), 1997, pp. 185-191
Authors:
ACOSTA EP
HENRY K
PAGE LM
ERICE A
BALFOUR HH
FLETCHER CV
Citation: Ep. Acosta et al., PHARMACOKINETICS AND SAFETY OF CONCENTRATION-CONTROLLED ORAL ZIDOVUDINE THERAPY, Pharmacotherapy, 17(3), 1997, pp. 424-430
Authors:
FLETCHER CV
GOODROAD BK
CUMMINS LM
HENRY K
BALFOUR HH
RHAME FS
Citation: Cv. Fletcher et al., PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS IMMUNOGLOBULIN IN PERSONS WITH AIDS, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1571-1574
Authors:
LAMBERT JS
MOFENSON LM
FLETCHER CV
MOYE J
STIEHM ER
MEYER WA
NEMO GJ
MATHIESON BJ
HIRSCH G
SAPAN CV
CUMMINS LM
JIMENEZ E
ONEILL E
KOVACS A
STEK A
Citation: Js. Lambert et al., SAFETY AND PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IMMUNOGLOBULIN ADMINISTERED TO HIV-INFECTED PREGNANT-WOMEN AND THEIR NEWBORNS, The Journal of infectious diseases, 175(2), 1997, pp. 283-291
Authors:
FLETCHER CV
Citation: Cv. Fletcher, PHARMACOLOGICAL CONSIDERATIONS FOR ANTIVIRAL DRUG DEVELOPMENT, The Annals of pharmacotherapy, 30(9), 1996, pp. 972-977
Authors:
ACOSTA EP
PAGE LM
FLETCHER CV
Citation: Ep. Acosta et al., CLINICAL PHARMACOKINETICS OF ZIDOVUDINE - AN UPDATE, Clinical pharmacokinetics, 30(4), 1996, pp. 251-262
Authors:
FLETCHER CV
BALFOUR HH
Citation: Cv. Fletcher et Hh. Balfour, VARIABILITY IN ZIDOVUDINE SERUM CONCENTRATIONS, Pharmacotherapy, 16(6), 1996, pp. 1154-1158
Authors:
BALFOUR HH
FLETCHER CV
ERICE A
HENRY WK
ACOSTA EP
SMITH SA
HOLM MA
BOIVIN G
SHEPP DH
CRUMPACKER CS
EATON CA
MARTINMUNLEY SS
Citation: Hh. Balfour et al., EFFECT OF FOSCARNET ON QUANTITIES OF CYTOMEGALOVIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS IN BLOOD OF PERSONS WITH AIDS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2721-2726
Authors:
KLINE MW
FLETCHER CV
FEDERICI ME
HARRIS AT
EVANS KD
RUTKIEWICZ VL
SHEARER WT
DUNKLE LM
Citation: Mw. Kline et al., COMBINATION THERAPY WITH STAVUDINE AND DIDANOSINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - PHARMACOKINETIC PROPERTIES, SAFETY, AND IMMUNOLOGICAL AND VIROLOGICAL EFFECTS, Pediatrics, 97(6), 1996, pp. 886-890
Authors:
KLINE MW
FLETCHER CV
FEDERICI ME
HARRIS AT
EVANS KD
RUTKIEWICZ VL
SHEARER WT
DUNKLE LM
Citation: Mw. Kline et al., COMBINATION THERAPY WITH STAVUDINE (D4T) AND DIDANOSINE (DDI) IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Pediatric research, 39(4), 1996, pp. 1039-1039
DISPOSITION OF ZIDOVUDINE IN OBESE PREGNANT-WOMEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors:
ACOSTA EP
SCHWEBKE K
HENRY K
FLETCHER CV
Citation: Ep. Acosta et al., DISPOSITION OF ZIDOVUDINE IN OBESE PREGNANT-WOMEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 174(3), 1996, pp. 673-673
Authors:
BRICELAND LL
CLEARY JD
FLETCHER CV
HEALY DP
PELOQUIN CA
Citation: Ll. Briceland et al., RECENT ADVANCES - ANTIINFECTIVES, The Annals of pharmacotherapy, 29(10), 1995, pp. 1035-1040
Authors:
SCHWEBKE K
FLETCHER CV
ACOSTA EP
HENRY K
Citation: K. Schwebke et al., PENTAMIDINE CONCENTRATIONS IN A MOTHER WITH AIDS AND IN HER NEONATE, Clinical infectious diseases, 20(6), 1995, pp. 1569-1570
Authors:
ACOSTA EP
FLETCHER CV
Citation: Ep. Acosta et Cv. Fletcher, ANTIRETROVIRAL DRUG-INTERACTIONS, International journal of antimicrobial agents, 5(2), 1995, pp. 73-83
Authors:
FLETCHER CV
HENRY WK
NOORMOHAMED SE
RHAME FS
BALFOUR HH
Citation: Cv. Fletcher et al., THE EFFECT OF CIMETIDINE AND RANITIDINE ADMINISTRATION WITH ZIDOVUDINE, Pharmacotherapy, 15(6), 1995, pp. 701-708
Authors:
NOORMOHAMED SE
HENRY WK
RHAME FS
BALFOUR HH
FLETCHER CV
Citation: Se. Noormohamed et al., STRATEGIES FOR CONTROL OF ZIDOVUDINE CONCENTRATIONS IN SERUM, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2792-2797
Authors:
FLETCHER CV
ACOSTA EP
STRYKOWSKI JM
Citation: Cv. Fletcher et al., GENDER DIFFERENCES IN HUMAN PHARMACOKINETICS AND PHARMACODYNAMICS, Journal of adolescent health, 15(8), 1994, pp. 619-629
Authors:
KOEHNTOP DE
NOORMOHAMED SE
FLETCHER CV
Citation: De. Koehntop et al., EFFECTS OF LONG-TERM DRUGS ON ALFENTANIL CLEARANCE IN PATIENTS UNDERGOING RENAL-TRANSPLANTATION, Pharmacotherapy, 14(5), 1994, pp. 592-599
Authors:
FLETCHER CV
COLLIER AC
RHAME FS
BENNETT D
PARA MF
BEATTY CC
JONES CE
BALFOUR HH
Citation: Cv. Fletcher et al., FOSCARNET FOR SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 604-607
Authors:
ACOSTA EP
FLETCHER CV
Citation: Ep. Acosta et Cv. Fletcher, AGENTS FOR TREATING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, American journal of hospital pharmacy, 51(18), 1994, pp. 2251-2267
Authors:
FLETCHER CV
Citation: Cv. Fletcher, CURRENT PERSPECTIVES ON ANTIRETROVIRAL THERAPY, Pharmacotherapy, 13(6), 1993, pp. 627-633
Authors:
FLETCHER CV
ACOSTA EP
Citation: Cv. Fletcher et Ep. Acosta, ADVANCES IN PHARMACOTHERAPY - TREATMENT OF HIV-INFECTION, Journal of clinical pharmacy and therapeutics, 18(6), 1993, pp. 375-388
Risultati:
1-24
|